- Home
- Anti Malarial drug
WHO ends hydroxychloroquine trial for COVID-19
Scientists find no survival benefit of treating COVID-19 patients with HCQ
Lancet retracts study that linked HCQ to increased death risk
WHO approves trial of HCQ for potential COVID-19 treatment
WHO suspends COVID-19 trials of HCQ over safety issues
Hydroxychloroquine linked to increased risk of death in hospitalized Covid-19 patients: Study
Covid-19: West Bengal to ramp up the production of Hydroxychloroquine
India to export HCQ only to foreign govts and not to pvt companies: Sources
Latest Additions
‘Bengaluru Chalo’ protest demand rejection of Kasturirangan Report
Mangaluru: Cyber frauds posing as TRAI representatives fleece Rs 1.71 crore
10 month baby gets new heart, new life
Saura Swasthya launched: Karnataka to power 5,000 health facilities with solar energy
India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges